Allen (Qinglin) Che
Senior Director, Drug Substance Development & Manufacturing at NewAmsterdam Pharma Corporation | United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
As the Associate Director of Drug Substance CMC at Relay Therapeutics, Allen plays a pivotal role in advancing the company’s mission to revolutionize small molecule therapeutic discovery, particularly in the realm of targeted oncology. With a robust background as an organic chemist and CMC professional, he expertly navigates the complexities of drug substance development, ensuring that projects progress smoothly through all stages of the development lifecycle. Allen's proficiency in discovery chemistry and process chemistry allows him to lead the design and optimization of synthetic routes, while his expertise in crystallization and drug substance manufacturing ensures that the resulting compounds meet stringent quality standards.
At Relay Therapeutics, Allen has successfully led and co-led the chemical development and manufacturing of seven key projects, demonstrating his ability to manage timelines and deliverables in fast-paced, timeline-driven environments. His comprehensive understanding of CMC regulatory requirements and Good Manufacturing Practice (GMP) compliance is instrumental in facilitating seamless technology transfers and collaborations with Contract Manufacturing Organizations (CMOs).
In addition to his technical acumen, Allen's project management skills enable him to coordinate cross-functional teams effectively, aligning business strategy with technical operations to drive project success. His insights into process simulation and optimization further enhance the efficiency of drug substance development, ensuring that Relay Therapeutics remains at the forefront of innovation in the pharmaceutical industry. As he continues to leverage his expertise, Allen is committed to overcoming the challenges associated with drugging previously intractable protein targets, ultimately contributing to the advancement of life-saving therapies for patients.
Senior Director, Drug Substance Development & Manufacturing at NewAmsterdam Pharma Corporation in October 2024 to Present
Director, Drug substance CMC at Relay Therapeutics in July 2022 to October 2024
Associate Director, Drug Substance CMC at Relay Therapeutics in September 2020 to June 2022
Principal Scientist, Project leader, CMC at Enanta Pharmaceuticals in April 2018 to September 2020
Technical Lead, Sr Scientist, API Manufacturing at Tetraphase Pharmaceuticals in May 2015 to April 2018
Senior Scientist, Chemical Development and Manufacturing at Synta Pharmaceuticals in July 2012 to May 2015
Consultant of Chemistry at Celgene in March 2012 to June 2012
Scientist II, Process Chemistry at Synta Pharmaceuticals in February 2011 to February 2012
Scientist II, Medicinal Chemistry at Synta Pharmaceuticals in March 2008 to January 2011
Scientist I, Medicinal chemistry at Synta Pharmaceuticals in October 2005 to February 2008
Chemistry Intern at Procter & Gamble in May 2002 to August 2002
See more
See less
Dalian University of Technology, Bachelor's Degree
Brandeis University, PhD, January 2001 to January 2005
Northeastern University, Graduate Certificate
Dalian University of Technology, Bachelor's Degree
See more
See less
Manufacturing Process Improvement
Failure Mode and Effects Analysis (FMEA)
Quality Assurance
Project Management
Team Management
Request for Proposal (RFP)
ICH
Drug Discovery
Medicinal Chemistry
Organic Chemistry
Drug Development
Process Development
Technology Transfer
Outsourcing
Regulatory Affairs
Chemistry
Organic Synthesis
Biotechnology
Chromatography
Life Sciences
Oncology
HPLC
Process Simulation
Analytical Chemistry
Lifesciences
CRO
CRO Management
Good Manufacturing Practice (GMP)
U.S. Food and Drug Administration (FDA)
Formulation
IND
Research and Development (R&D)
Pharmaceutical Industry
CDMOS
CMO management
Synthetic Organic Chemistry
Vendor Management
CMC Regulatory Affairs
scale up
Design of Experiments
Quality by Design
Process Validation
New Drug Application (NDA)
IMPD
Common Technical Document (CTD)
Chinese
Business
Supply Chain Management
Business Strategy
API Development
Regulatory Submissions
Leadership
Technical Operations
See more
See less
What is Allen email address?
Email Allen at [email protected], [email protected] and [email protected]. This email is the most updated Allen's email found in 2026.
What is Allen phone number?
Allen phone number is +1.7817386793.
How to contact Allen?
To contact Allen send an email to [email protected], [email protected] or [email protected]. If you want to call Allen try calling on +1.7817386793.
What company does Allen (Qinglin) Che work for?
Allen (Qinglin) Che works for NewAmsterdam Pharma Corporation
What is Allen (Qinglin) Che's role at NewAmsterdam Pharma Corporation?
Allen (Qinglin) Che is Senior Director, Drug Substance Development & Manufacturing
What industry does Allen (Qinglin) Che work in?
Allen (Qinglin) Che works in the Pharmaceuticals industry.
Allen (Qinglin) Che Email Addresses
Allen (Qinglin) Che Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.